Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
about
Association Between Inflammatory Bowel Disease and Vitamin D DeficiencyIsotretinoin use and the risk of inflammatory bowel disease: a case-control studyVedolizumab for the treatment of ulcerative colitis and Crohn's diseaseThe role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitisIntestinal inflammation and the diet: Is food friend or foe?Budesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisQuality improvement in pediatric inflammatory bowel disease: moving forward to improve outcomesEnteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsRNA interference-based nanosystems for inflammatory bowel disease therapyThe burden of inflammatory bowel disease in EuropeSearching for the delta: 5-aminosalicylic Acid therapy for Crohn's diseasePhysical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohortsFire in the belly and the professionalization of nurses: a historical analysis of Crohn disease care.Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners).Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.Inflammatory bowel disease: an expanding global health problemRole of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazineCurrent approaches to the management of new-onset ulcerative colitis.Differing Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease.Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran populationHigh end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease.Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice.Topiramate use does not reduce flares of inflammatory bowel diseaseEmerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.Approaches to improve quality of care in inflammatory bowel diseases.Stem cells as potential therapeutic targets for inflammatory bowel disease.Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.Purine-metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells.Utilization of healthcare resources by U.S. children and adults with inflammatory bowel diseaseDifferences in healthcare expenditures for inflammatory bowel disease by insurance status, income, and clinical care setting.13-year mortality trends among hospitalized patients with inflammatory bowel diseaseMethotrexate: underused and ignored?Circulating fibrocytes and Crohn's disease.Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.Dietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethane-dextran sodium sulphate-treated mice.Risk of diagnosed fractures in children with inflammatory bowel diseases.Increased epithelial gaps in the small intestine are predictive of hospitalization and surgery in patients with inflammatory bowel diseaseAltered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation.Complex home care: Part I--Utilization and costs to families for health care services each year.
P2860
Q22242722-3757A8AC-ECFA-4C3D-9FC8-7CCF6C3548C3Q24621195-17EE8A9E-9680-4480-ACD9-8F81FA75B73FQ24630083-FDF37A78-95D1-45EE-AD97-810BE43B2EDAQ26748626-976D250C-BB61-4C34-B141-791FF1EEF577Q26765223-D5377259-AD8B-4582-97AE-7C530819CB85Q26779042-8DEF04A8-F68D-4EE7-BD0A-F9D8CB9F5874Q26996289-8EA07D3D-280F-4E91-B7C9-3C2F1BDA8D59Q27027602-492A930D-880F-4698-A839-AABF7068E8AEQ28071518-760578B5-6051-40DB-9A95-79A8ECFA618DQ28285200-A50F16F7-F667-4D1E-8DEA-A03DF5020495Q28390019-037A5789-7B7B-46BD-A2C8-2DBC21B30736Q28658603-C75DCD66-BD67-44B1-BCB0-7AD69A60280EQ30415482-94A22093-CC54-4B9D-A772-BDE3896CCA05Q30770055-B0089B11-A4D4-49F4-AD29-F7D91D86219CQ33427772-B6E3C630-70E6-45DA-9E61-AF6EE31775B6Q33608406-EE79F3BD-35AC-4AAB-9328-7314B5F55D41Q33628518-29C9C483-3E23-4F89-9B91-B57B194CA5F6Q33633288-AD3C9DFF-09F4-480B-A2FB-E68A1D08D1B7Q33658943-FD8FDE02-8946-4A48-BC6D-BEB2919BD52AQ33667897-E2556A94-38A9-45E6-B492-80CF07A70D3AQ33674784-E13998F7-6F6C-4593-9BBF-8DEF85102ECFQ33719997-7B42A634-199A-4932-B19A-1D1449CD0538Q33735563-D6063739-83D2-4337-80BB-E11014006BB8Q33807261-44889975-CD25-4634-BDCB-63A2C3D06459Q33916303-E4A96101-E949-47EF-B9C4-52D9158B7C88Q33948298-390CFAB6-87AD-4D5C-B747-19EEBD1A3600Q33975300-8FF878E3-7ACF-463D-8708-7D3A746DF150Q34143148-A57EA214-F181-4C26-AF1C-2089CF11F4CEQ34152663-444EE43D-9232-4A19-A653-3EF32567A31DQ34233590-3DE9F75D-8E1D-48A1-A498-669C60A16125Q34264216-F6B1C9C7-3175-488B-BC22-DBAB02AB85E6Q34317501-84C8F577-7C60-452F-B49A-FEB34EF86628Q34321255-A28A5D7F-D840-4403-B290-92F17C584F90Q34387011-A101E7C1-6300-4B65-BBD9-A07AA92132E8Q34420368-C0E861C7-612A-4F55-BF2C-036F5889B2C6Q34424300-000BFCEA-D0D9-4CE9-85A4-87523F91B484Q34448516-2D893AF3-EAF8-490F-81D3-59E375078395Q34511806-D83D98EB-C0A2-431D-A975-793756E39674Q34792072-757A20C1-FF67-4EBD-9831-54EE147D48D9Q35005342-6CD842AD-881C-49B5-A1E9-37E48F9256C9
P2860
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Direct health care costs of Cr ...... tis in US children and adults.
@en
Direct health care costs of Cr ...... tis in US children and adults.
@nl
type
label
Direct health care costs of Cr ...... tis in US children and adults.
@en
Direct health care costs of Cr ...... tis in US children and adults.
@nl
prefLabel
Direct health care costs of Cr ...... tis in US children and adults.
@en
Direct health care costs of Cr ...... tis in US children and adults.
@nl
P2093
P2860
P1433
P1476
Direct health care costs of Cr ...... tis in US children and adults.
@en
P2093
Carol Q Porter
Daniel A Ollendorf
Jonathan A Finkelstein
Joseph A Galanko
Michael D Kappelman
Sheryl L Rifas-Shiman
P2860
P304
P356
10.1053/J.GASTRO.2008.09.012
P407
P577
2008-09-17T00:00:00Z